Kurse + Charts + RealtimeNews + AnalysenFundamentalUnternehmenzugeh. WertpapiereAktion
Kurs + ChartChart (groß)NewsBilanz/GuVDividende/HVZertifikateDepot/Watchlist
Times + SalesChart-AnalyseAnalysenSchätzungenTermineOptionsscheinemyHome
BörsenplätzeChartvergleichKurszieleVergleichProfilKnock-OutsSenden
OrderbuchRealtime StuttgartFundamentalanalyse InsidertradesFondsInvestmentreport
HistorischRealtime PushmyNewsAusblickim ForumAnleihen
Kaufen
Verkaufen

MorphoSys News

  • Sprache:
  • Alle
  • DE
  • EN
  • Sortieren:
  • Datum
  • meistgelesen
29.05.15
MorphoSys to Present at Five Upcoming Conferences (Globe Newswire)
21.05.15
MorphoSys to Present Data on Proprietary Programs at 20th Congress of the European Hematology Association (Globe Newswire)
13.05.15
MorphoSys to Present Data on Proprietary Programs at American Society of Clinical Oncology Annual Meeting (Globe Newswire)
12.05.15
MorphoSys to Present at Two Upcoming Investor Conferences (Globe Newswire)
08.05.15
Annual General Meeting of MorphoSys AG Elects New Supervisory Board Members (Globe Newswire)
07.05.15
MorphoSys Acquires Peptide Therapeutic Company Lanthio Pharma (Globe Newswire)
07.05.15
Ad hoc: MorphoSys Acquires Peptide Therapeutic Company Lanthio Pharma (Hugin)
05.05.15
MorphoSys AG Reports Results for the First Three Months of 2015 (Globe Newswire)
29.04.15
MorphoSys to Host Q1 2015 Conference Call on 05 May 2015 (Globe Newswire)
14.04.15
MorphoSys to Present at Kempen & Co Life Sciences Conference (Globe Newswire)
13.04.15
MorphoSys AG : MorphoSys to Receive Milestone Payment for Guselkumab Program in Psoriatic Arthritis (Globe Newswire)
08.04.15
MorphoSys to Start Share Buy-Back Program (Globe Newswire)
08.04.15
Ad hoc: MorphoSys to Start Share Buy-Back Program (Hugin)
30.03.15
MorphoSys Nominates Three New Candidates for Supervisory Board (Globe Newswire)
27.03.15
MorphoSys to Host Conference Call on Announcement Regarding the Termination of the Co-development and Co-promotion Agreement for MOR202 (Globe Newswire)
26.03.15
MorphoSys AG : MorphoSys and Celgene Mutually Agree to End MOR202 Collaboration (Globe Newswire)
26.03.15
Ad hoc: MorphoSys and Celgene Mutually Agree to End MOR202 Collaboration and MorphoSys Updates its Financial Guidance for 2015 (Hugin)
09.03.15
Emergent BioSolutions and MorphoSys Initiate Phase 1 Clinical Study to Evaluate the Novel Oncology Immunotherapeutic MOR209/ES414 for Prostate Cancer (Globe Newswire)
09.03.15
MorphoSys and Emergent BioSolutions Initiate Phase 1 Clinical Study to Evaluate the Novel Oncology Immunotherapeutic MOR209/ES414 for Prostate Cancer (Globe Newswire)
26.02.15
MorphoSys AG Reports Results for Fiscal Year 2014 (Globe Newswire)
20.02.15
Invitation to Year End 2014 Conference Call of MorphoSys AG on 26 February 2015 (Globe Newswire)
10.02.15
MorphoSys to Present at Leerink Global Healthcare Conference (Globe Newswire)
08.01.15
MorphoSys to Present at J.P. Morgan Healthcare Conference (Globe Newswire)
22.12.14
MorphoSys AG: Corporate Calendar 2015 (Globe Newswire)
22.12.14
MorphoSys Announces Clinical Milestone in Oncology Program (Globe Newswire)
19.12.14
Ad hoc: MorphoSys's Partner Roche Provides Update on Trial of Gantenerumab in Prodromal Alzheimer's Patients (Hugin)
08.12.14
MorphoSys Presents Updated Phase 2 Clinical Results for MOR208 Monotherapy in NHL at American Society of Hematology Meeting (Globe Newswire)
07.12.14
MorphoSys and Xencor Publish Final Results from Phase 1/2a Trial of MOR208 (XmAb5574) in CLL/SLL at ASH Annual Meeting (Globe Newswire)
18.11.14
MorphoSys to Present at Two Upcoming Investor Conferences (Globe Newswire)
07.11.14
MorphoSys AG Reports Results for the First Nine Months of 2014 (Globe Newswire)
06.11.14
MorphoSys to Present Data on Proprietary Programs at American Society of Hematology Annual Meeting (Globe Newswire)
30.10.14
MorphoSys to Host Q3 2014 Conference Call on 07 November 2014 (Globe Newswire)
23.10.14
MorphoSys to Receive Milestone Payment for Guselkumab Phase 3 Program (Globe Newswire)
23.10.14
Ad hoc: MorphoSys Updates its 2014 Financial Guidance (Globe Newswire)
22.10.14
Ad hoc: MorphoSys Updates its 2014 Financial Guidance (Hugin)
20.10.14
MorphoSys Announces Clinical Milestone in Ophthalmology Program (Globe Newswire)
15.10.14
MorphoSys Acquires Lanthipeptide Technology from Lanthio Pharma (Globe Newswire)
15.09.14
MorphoSys Receives Research Grant to Develop Novel Therapeutic Antibodies Targeting GPCRs (Globe Newswire)
04.09.14
MorphoSys to Present at Six Investor Conferences in September (Globe Newswire)
20.08.14
MorphoSys to Host Conference Call on License Agreement with Emergent to Co-Develop and Commercialize Prostate Cancer Drug Candidate MOR209/ES414 (Globe Newswire)
Seite: 12

MorphoSys News

MorphoSys News: auf dieser Seite finden Sie alle MorphoSys News und Nachrichten zur MorphoSys Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch MorphoSys News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um MorphoSys News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.